hydrogen carbonate has been researched along with ro13-9904 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Moore, EW; Purdum, PP; Shiffman, ML | 1 |
| Fukata, Y; Minakuchi, J; Nishiuchi, Y; Okada, K; Okamoto, T; Shima, H; Takamatsu, N; Tao, T | 1 |
| Fueyo-Rodriguez, O; Moreno-Sanchez, F; Palomar-Lever, A; Valente-Acosta, B | 1 |
1 review(s) available for hydrogen carbonate and ro13-9904
| Article | Year |
|---|---|
Hypersensitivity reactions to bicarbonate dialysate containing acetate: a case report with literature review.
Topics: Acetates; Aged; Anti-Bacterial Agents; Bicarbonates; C-Reactive Protein; Ceftriaxone; Dialysis Solutions; Drug Hypersensitivity; Eosinophils; Fever; Hemodiafiltration; Humans; Male; Pneumonia; Renal Dialysis | 2020 |
2 other study(ies) available for hydrogen carbonate and ro13-9904
| Article | Year |
|---|---|
In vivo studies of biliary ceftriaxone excretion and solubility in guinea pig hepatic bile.
Topics: Animals; Anions; Bicarbonates; Bile; Calcium; Ceftriaxone; Chlorides; Female; Guinea Pigs; Liver; Sodium; Solubility; Taurocholic Acid | 1992 |
Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19.
Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Azithromycin; Betacoronavirus; Bicarbonates; Ceftriaxone; Coronavirus Infections; COVID-19; Cytochrome P-450 CYP3A Inhibitors; Enoxaparin; Enzyme Inhibitors; Fluid Therapy; Humans; Hydroxychloroquine; Lopinavir; Lung; Male; Pandemics; Pneumonia, Viral; Respiration, Artificial; Rhabdomyolysis; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |